You have 9 free searches left this month | to do more
Showing 1 - 25 of
6,099 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
Recruiting
  • Non Hodgkin Lymphoma
  • +2 more
  • Fully human anti CD19 CAR-T Cell Dose
  • +2 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
2022-03-10
Mar 10, 2022
W
Recruiting
  • T-Cell Lymphocytic Leukemia
  • +2 more
  • Fludarabine + Cyclophosphamide + CAR7-T Cells
  • Wuhan, Hubei, China
    Union Hospital, Huazhong University of Science and Technology
2022-03-01
Mar 1, 2022
A
Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • complete blood count
  • (no location specified)
2022-02-15
Feb 15, 2022
P
Recruiting
  • Acute Myeloid Leukemia
  • Acute Lymphoid Leukemia
    • Montería, Colombia
      Oncomedica SA
    2022-01-05
    Jan 5, 2022
    N
    Completed
    • Chronic Lymphocytic Leukemia (CLL)
      • (no location specified)
      2022-04-05
      Apr 5, 2022
      U
      Recruiting
      • Chronic Lymphoid Leukaemia
        • Brest, France
          CHRU de Brest
        2021-01-27
        Jan 27, 2021
        U
        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • [U-13C]glucose
        • [13C5]glutamine
        • (no location specified)
        2022-03-18
        Mar 18, 2022
        U
        Recruiting
        • Chronic Lymphoid Leukemia in Relapse
        • Belimumab 200 MG/ML [Benlysta]
        • standard of care
        • Tuebingen, BW, Germany
          University Hospital Tuebingen, CCU Translational Immunology
        2022-02-02
        Feb 2, 2022
        T
        Completed
        • CLL
          • Tampere, Finland
            Tampere university Hospital
          2022-02-22
          Feb 22, 2022
          G
          Not yet recruiting
          • Chemotherapy
          • Leukemia, Acute Lymphoblastic
          • (no location specified)
          2022-03-23
          Mar 23, 2022
          N
          Recruiting
          • Chronic Lymphocytic Leukemia
          • Taipei, Taiwan
            National Taiwan University Hospital
          2021-10-27
          Oct 27, 2021
          B
          Recruiting
          • Acute Lymphoblastic Leukemia
          • +2 more
          • chimeric antigen receptor T cell
          • Beijing, Beijing, China
            Beijing Boren Hospital
          2022-01-25
          Jan 25, 2022
          H
          Recruiting
          • Large Granular Lymphocyte Leukemia
          • Tampa, Florida
            Moffitt Cancer Center
          2022-03-30
          Mar 30, 2022
          D
          Recruiting
          • Chronic Lymphocytic Leukemia
            • Boston, Massachusetts
              Dana Farber Cancer Institute
            2021-07-14
            Jul 14, 2021
            N
            Enrolling by invitation
            • Acute Lymphoblastic Leukemia
            • +4 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              2022-04-07
              Apr 7, 2022
              J
              Active, not recruiting
              • Leukemia, Lymphocytic, Chronic, B-Cell
              • Lymphoma, Mantle-Cell
              • Paris Cedex 13, France
                (unnamed)
              2022-03-24
              Mar 24, 2022
              M
              Active, not recruiting
              • B-Lymphoid Malignancies
              • +3 more
              • Houston, Texas
                University of Texas MD Anderson Cancer Center
              2021-11-18
              Nov 18, 2021
              M
              Recruiting
              • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
              • +2 more
              • Houston, Texas
                University of Texas MD Anderson Cancer Center
              2021-10-29
              Oct 29, 2021
              S
              Not yet recruiting
              • Leukemia, Lymphocytic, Chronic, B-Cell
              • JWCAR029 (Relmacabtagene Autoleucel)
              • Nanjing, Jiangsu, China
                Jiangsu Province Hospital
              2022-02-17
              Feb 17, 2022
              C
              Enrolling by invitation
              • Acute Lymphoblastic Leukemia, Pediatric
              • Adverse Drug Event
                • Stanford, California
                  Stanford University
                2022-03-07
                Mar 7, 2022
                M
                Completed
                • CLL
                • Leukemia
                • Houston, Texas
                  University of Texas MD Anderson Cancer Center
                2022-03-14
                Mar 14, 2022
                N
                Recruiting
                • Acute Lymphoid Leukemia
                • +4 more
                • CD19/CD22 CAR T-Cells
                • +2 more
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center
                2022-04-07
                Apr 7, 2022
                U
                Recruiting
                • Leukemia, Lymphocytic, Chronic, B-Cell
                • Abnormalities Cell Epithelial
                  • Zurich, Switzerland
                    University Hospital Zurich
                  2021-10-05
                  Oct 5, 2021